2-oxo-1,2-dihydro-quinoline modulators of immune function

Details for Australian Patent Application No. 2009288108 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Gant, Thomas G.; Shahbaz, Manouchehr M.

Agent FB Rice

Pub. Number AU-A-2009288108

PCT Pub. Number WO2010/028015

Priority 61/093,943 03.09.08 US

Filing date 2 September 2009

Wipo publication date 11 March 2010

International Classifications

C07D 215/58 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/198 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/028015 Priority application(s): WO2010/028015

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009288118-Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof

2009288097-Pathways underlying pancreatic tumorigenesis and an hereditary pancreatic cancer gene